Blue Jet Healthcare Limited (BLUEJET.NS)
INR 723.25
(1.7%)
INR 723.25
(1.7%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 7.11 Billion INR | -0.96% |
| 2022 | 7.18 Billion INR | 6.16% |
| 2021 | 6.76 Billion INR | 36.94% |
| 2020 | 4.94 Billion INR | -8.17% |
| 2019 | 5.38 Billion INR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 2.08 Billion INR | 27.85% |
| 2024 Q1 | 1.62 Billion INR | -11.44% |
| 2023 Q2 | 1.81 Billion INR | 1.51% |
| 2023 Q3 | 1.66 Billion INR | -8.05% |
| 2023 Q1 | 1.78 Billion INR | -17.61% |
| 2023 Q4 | 1.83 Billion INR | 10.31% |
| 2023 FY | 7.11 Billion INR | -0.96% |
| 2022 Q1 | 1.44 Billion INR | 0.0% |
| 2022 FY | 7.18 Billion INR | 6.16% |
| 2022 Q4 | 2.16 Billion INR | 28.34% |
| 2022 Q3 | 1.68 Billion INR | -11.18% |
| 2022 Q2 | 1.9 Billion INR | 32.07% |
| 2021 FY | 6.76 Billion INR | 36.94% |
| 2020 FY | 4.94 Billion INR | -8.17% |
| 2019 FY | 5.38 Billion INR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Biocon Limited | 147.55 Billion INR | 95.177% |
| Concord Biotech Limited | 9.98 Billion INR | 28.702% |
| Dishman Carbogen Amcis Limited | 26.15 Billion INR | 72.796% |
| Jubilant Ingrevia Limited | 41 Billion INR | 82.646% |
| Lyka Labs Limited | 1.05 Billion INR | -576.86% |
| Panacea Biotec Limited | 5.59 Billion INR | -27.26% |
| Piramal Pharma Limited | 81.71 Billion INR | 91.291% |
| SMS Lifesciences India Limited | 3.05 Billion INR | -132.58% |
| Supriya Lifescience Limited | 5.7 Billion INR | -24.761% |
| Syngene International Limited | 34.88 Billion INR | 79.602% |
| TAKE Solutions Limited | 656.08 Million INR | -984.621% |
| Zota Health Care Limited | 1.8 Billion INR | -294.262% |